Answers are grounded in this paper and cite their sources.
Shows diffusion kurtosis MRI predicts treatment response and cellular invasion in hepatocellular carcinoma after chemoembolization, indicating utility for recurrence monitoring.
BACKGROUND: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide. Transcatheter arterial chemoembolization (TACE) has been performed as a palliative treatment for patients with HCC. However, HCC is easy to recur after TACE. Magnetic resonance imaging (MRI) has clinical potential in evaluating the TACE treatment effect for patients with liver cancer. However, traditional MRI has some limitations. AIM: To explore the clinical potential of diffusion kurtosis imaging (DKI) in predicting recurrence and cellular invasion of the peritumoral liver zone of HCC after TACE. CONCLUSION: DKI has been demonstrated with robust performance in predicting the therapeutic response of HCC to TACE. Moreover, DKI might reveal cellular invasion of the peritumoral zone by molecular diffusion-restricted change.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: